These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A, Sawada K, Nakamura K, Kinose Y, Nakatsuka E, Kobayashi M, Miyamoto M, Ishida K, Matsumoto Y, Kodama M, Hashimoto K, Mabuchi S, Kimura T. BMC Cancer; 2018 Nov 05; 18(1):1065. PubMed ID: 30396333 [Abstract] [Full Text] [Related]
9. Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma. Yoshino H, Tatarano S, Tamai M, Tsuruda M, Iizasa S, Arima J, Kawakami I, Fukumoto W, Kawahara I, Li G, Sakaguchi T, Inoguchi S, Yamada Y, Enokida H. Biochem Biophys Res Commun; 2022 Nov 19; 630():71-76. PubMed ID: 36150242 [Abstract] [Full Text] [Related]
11. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J. PLoS One; 2015 Nov 19; 10(5):e0125672. PubMed ID: 25938468 [Abstract] [Full Text] [Related]
14. Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma. Ryu KJ, Lee JY, Choi ME, Yoon SE, Cho J, Ko YH, Shim JH, Kim WS, Park C, Kim SJ. Cancers (Basel); 2020 Nov 27; 12(12):. PubMed ID: 33261029 [Abstract] [Full Text] [Related]
18. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B, Zhang Y, Ye M, Wu J, Ma L, Chen H. Curr Drug Metab; 2019 Nov 27; 20(10):804-814. PubMed ID: 31424364 [Abstract] [Full Text] [Related]
19. Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma. Fujii N, Hirata H, Ueno K, Mori J, Oka S, Shimizu K, Kawai Y, Inoue R, Yamamoto Y, Matsumoto H, Shimabukuro T, Udoh K, Hoshii Y, Dahiya R, Matsuyama H. Oncotarget; 2017 Dec 15; 8(66):109877-109888. PubMed ID: 29299115 [Abstract] [Full Text] [Related]